Skip to main content
. 2025 Jan 23;46:e-rbgo97. doi: 10.61622/rbgo/2024rbgo97

Table 2. Comparison of laboratory results of preeclampsia and control groups.

Comparasion Preeclampsia Group (n=66) Mean± SD Median (Min-Max) Control Group (n=68) Mean ± SD Median (Min-Max) p-value
Hemoglobin (g/dl) 12.1±1.5 11.9 (8.3-15.3) 11.9±3.1 11.7 (8.5-13.9) 0.093
Hematocrit (%) 36.8±4.1 36.3 (26.1-49.4) 34.8±4.5 34.9 (11.5-41.4) 0.036*
Leukocyte (/mm3) 10976.5±2710.4 10680 (5380-20900) 10831.3±3220.4 10430 (5790-23320) 0.445
Platelet (/mm3) 238197±73836 243500(64000-457000) 233485.3±71958.6 225000(128000-423000) 0.476
Fibrinogen (mg/dl) 503.4±95.6 515.0 (265-763) 504.3±86.5 504.5 (276-708) 0.956
Creatinine (mg/dl) 0.6±0.1 0.5 (0.3-1.1) 0.4±0.1 0.4 (0.3-0.6) <0.001*
Uric Acid (mg/dl) 5.2±1.4 5.4 (2.7-10.0) 3.5±1.2 3.2 (1.6-7.0) <0.001*
Spot urine protein/Creatinine 1.0±1.2 0.6 (0.1-6.1) 0.1±0.1 0.1 (0.1-0.2) <0.001*
24 Hour urine protein (mg) 978.4±1198.9 462 (129-60002) 241.5±55.9 241.5 (202-281) 0.002*
Na (mEq/L) 135.7±2.1 136 (131-140) 136.9±1.8 137 (133-141) 0.002*
AST (U/L) 21.4 ±19.2 16 (10-155) 15.6±5.6 14.0 (6-38) 0.002*
ALT (U/L) 18.5±32.8 11.5 (4-263) 10.3±5.8 8 (1-32) 0.008*
LDH (U/L) 248.3±83.6 223 (147-559) 189.3±30.2 192 (127-268) <0.001*
INR 1.0±0.1 1.0 (0.9-1.5) 1.01±0.1 1.0 (0.9-1.2) 0.003*
IMA (ABSU) 1.02±0.15 1.02 (0.66-1.44) 0.93±0.10 0.94 (0.66-1.16) <0.001*

Na – Sodium; AST - aspartate aminotransferase; ALT - alanine aminotransferase; LDH - lactate dehydrogenase; INR - international normalized ratio; IMA - ischemia modified albümin; *Statistically significant at p < 0.05 (Laboratory results at the time of admission)